Natali P G, Cavaliere R, Bigotti A, Nicotra M R, Russo C, Ng A K, Giacomini P, Ferrone S
J Immunol. 1983 Mar;130(3):1462-6.
The antigenic heterogeneity of primary and metastatic lesions surgically removed from nine patients with nodular melanoma was investigated by using monoclonal antibodies to HLA-A, B antigens, to beta 2-microglobulin, to Ia antigens, and to melanoma-associated antigens (MAA). The latter include three types of membrane-bound MAA and a cytoplasmic MAA. In spite of an homogeneous morphologic appearance, multiple lesions removed from the same patient differed significantly in their reactivity with the panel of monoclonal antibodies in indirect immunofluorescence test. The extent of antigenic heterogeneity did not correlate with melanin synthesis, site of origin of the primary tumor, site of metastatic foci, or treatment, but was less marked in patients carrying the primary tumor. The antigenic heterogeneity of multiple lesions removed from one patient and the independent expression of the various types of MAA investigated suggest that combinations of monoclonal antibodies to MAA may be more effective than single antibodies for radioimaging and immunotherapy.
通过使用针对HLA - A、B抗原、β2 - 微球蛋白、Ia抗原以及黑色素瘤相关抗原(MAA)的单克隆抗体,对9例结节性黑色素瘤患者手术切除的原发性和转移性病变的抗原异质性进行了研究。后者包括三种类型的膜结合MAA和一种细胞质MAA。尽管形态外观均一,但在间接免疫荧光试验中,从同一患者身上切除的多个病变与单克隆抗体组的反应性存在显著差异。抗原异质性的程度与黑色素合成、原发性肿瘤的起源部位、转移灶部位或治疗无关,但在携带原发性肿瘤的患者中不太明显。从一名患者身上切除的多个病变的抗原异质性以及所研究的各种类型MAA的独立表达表明,针对MAA的单克隆抗体组合可能比单克隆抗体在放射性成像和免疫治疗中更有效。